Lobo Wesley S. 4
4 · NEPHROS INC · Filed Sep 3, 2021
Insider Transaction Report
Form 4
NEPHROS INCNEPH
Lobo Wesley S.
Chief Marketing Officer
Transactions
- Award
Stock Option (right to buy)
2021-09-01+57,368→ 57,368 totalExercise: $8.47Exp: 2031-09-01→ Common Stock (57,368 underlying)
Holdings
- 114,178
Stock Optoin (right to buy)
Exercise: $8.66Exp: 2031-02-16→ Common Stock (114,178 underlying) - 41,557
Common Stock
Footnotes (3)
- [F1]Includes (i) 20,557 shares of restricted stock for which the risk of forfeiture will lapse on 2/16/22; and (ii) 20,000 shares of restricted stock for which the risk of forfeiture will lapse as to 5,000 shares on each of 2/16/22, 2/16/23, 2/16/24 and 2/16/25.
- [F2]Options to purchase 28,545 shares vest on 2/16/22 and options to purchase 85,633 shares vest quarterly in 12 equal amounts commencing on 5/16/22.
- [F3]Options to purchase 14,342 shares vest on 9/1/22 and options to purchase 43,026 shares vest quarterly in 12 equal amounts commencing on 12/1/22.